Research Article
[Retracted] Expression of CDK6 in Stomach Cancer and the Effect of CDK4/6 Inhibitor PD-0332991 on the Function of Stomach Cancer Cells
Table 1
Effects of CDK6 expression on clinicopathological characteristics of patients.
| Metric | CDK6 positive () | CDK6 negative () | value | value |
| Sex | | | 1.489 | 0.222 | Man | 24 | 45 | | | Woman | 7 | 14 | | | Age | | | 6.001 | 0.014 | <60 years old | 6 | 21 | | | The 60-year-old oneself | 25 | 38 | | | Tumor diameter | | | 1.795 | 0.18 | <5 cm | 15 | 20 | | | ≥5 cm | 16 | 39 | | | Tumor stage | | | 2.45 | 0.118 | I+II | 11 | 12 | | | III+IV | 20 | 47 | | | AJCC by stages | | | 1.034 | 0.309 | I-II | 15 | 22 | | | III-IV | 16 | 37 | | | T by stages | | | 0.02 | 0.886 | T1+T2 | 4 | 7 | | | T3+T4 | 27 | 52 | | | Lymphatic metastasis | | | 0.029 | 0.865 | N0 | 10 | 18 | | | N1-3 | 21 | 41 | | |
|
|